FORMULATIONS OF INTRAARTICULAR PHARMACEUTICAL AGENTS AND METHODS FOR PREPARING AND USING THE SAME
First Claim
1. A method for lubricating a joint of a mammal comprising administered into a cavity of the joint an effective amount of a composition comprising at least 0.6% polyethylene glycol (PEG), wherein the composition is a liquid at the temperature of the joint and the oncotic pressure of the composition is not greater than the serum oncotic pressure of the mammal.
1 Assignment
0 Petitions
Accused Products
Abstract
Provided herein are compositions and methods for preparing intraarticular formulations comprising biocompatible pharmaceutical agents and use thereof in the treatment of diseases, such as degenerative bone diseases, including osteoarthritis of the knee, hip, or other joints, and similar chronic or acute destructive arthropathies resulting from autoimmune disorders or infectious disease.
5 Citations
46 Claims
- 1. A method for lubricating a joint of a mammal comprising administered into a cavity of the joint an effective amount of a composition comprising at least 0.6% polyethylene glycol (PEG), wherein the composition is a liquid at the temperature of the joint and the oncotic pressure of the composition is not greater than the serum oncotic pressure of the mammal.
- 24. A method for lubricating a joint of a mammal comprising administered an effective amount of a composition comprising at least 10% polyethylene glycol 400 (PEG 400).
- 26. An intraarticular formulation comprising an effective concentration of polyethylene glycol (PEG) of at least 600,000.
- 36. An intraarticular formulation comprising a high molecular weight polyethylene glycol (PEG) and hydroxyethyl cellulose (HEC).
-
42. A method for lubricating a joint of a mammal comprising administered into a cavity of the joint an effective amount of a composition comprising petroleum jelly or silicon oil, and phosphatidylcholine, wherein the composition is a liquid at the temperature of the joint and the oncotic pressure of the composition is not greater than the serum oncotic pressure of the mammal.
-
43. A method for lubricating a joint of a mammal comprising administered into a cavity of the joint an effective amount of a composition comprising hydroxyethyl cellulose, wherein the composition is a liquid at the temperature of the joint and the oncotic pressure of the composition is not greater than the serum oncotic pressure of the mammal.
-
44. A method for lubricating a joint of a mammal comprising administered into a cavity of the joint an effective amount of a composition comprising hydroxyethyl cellulose and polyethylene glycol, wherein the composition is a liquid at the temperature of the joint and the oncotic pressure of the composition is not greater than the serum oncotic pressure of the mammal.
-
45. A method for lubricating a joint of a mammal comprising administered into a cavity of the joint an effective amount of a composition comprising hydroxyethyl cellulose, polyethylene glycol, carboxymethyl cellulose, and polyvinylpyrrolidone, wherein the composition is a liquid at the temperature of the joint and the oncotic pressure of the composition is not greater than the serum oncotic pressure of the mammal.
-
46. A method for lubricating a joint of a mammal comprising administered into a cavity of the joint an effective amount of a composition comprising hydroxyethyl cellulose, polyethylene glycol, and polyvinyl alcohol, wherein the composition is a liquid at the temperature of the joint and the oncotic pressure of the composition is not greater than the serum oncotic pressure of the mammal.
Specification